What is United Therapeutics's U.S. — total revenues?

United Therapeutics (UTHR) reported U.S. — total revenues of $744.2M in Q1 2026.

How has United Therapeutics's U.S. — total revenues changed year-over-year?

United Therapeutics's U.S. — total revenues decreased by 0.7% year-over-year, from $749.6M to $744.2M.

What is the long-term trend for United Therapeutics's U.S. — total revenues?

Over 4 years (2021 to 2025), United Therapeutics's U.S. — total revenues has grown at a 18.0% compound annual growth rate (CAGR), from $1.56B to $3.04B.

United Therapeutics UTHR U.S. — Total revenues

Other financials

Income statement

See full

Revenue$781.5M-1.6%

Gross profit$648.1M-7.7%

Operating income$325.8M-14.9%

Net income$274.9M-14.7%

EPS (diluted)$5.82-12.2%

Balance sheet

See full

Cash & equivalents$1.3B-32.6%

Total debt$12.2M—

Total equity$5.9B-13.3%

Total assets$6.7B-13.3%

Cash flow

See full

Operating cash flow$463.3M+0.5%

CapEx$100.8M+34.6%

Free cash flow$362.5M-6.2%

Valuation

See full

Market cap$26.25B+90.4%

P/E20.4×+9.3×

P/S8.3×+3.8×

Profitability

See full

Gross margin86.6%-2.4pp

Operating margin45.3%-1.6pp

Net margin40.6%+0.2pp

FCF margin32.1%-5.6pp

Returns & leverage

See full

Return on equity20.3%+0.3pp

Debt / equity0×—

Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's u.s. — total revenues.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is United Therapeutics's U.S. — total revenues?: United Therapeutics (UTHR) reported U.S. — total revenues of $744.2M in Q1 2026.
How has United Therapeutics's U.S. — total revenues changed year-over-year?: United Therapeutics's U.S. — total revenues decreased by 0.7% year-over-year, from $749.6M to $744.2M.
What is the long-term trend for United Therapeutics's U.S. — total revenues?: Over 4 years (2021 to 2025), United Therapeutics's U.S. — total revenues has grown at a 18.0% compound annual growth rate (CAGR), from $1.56B to $3.04B.